Efficacy and Safety of Open-Conjunctiva Ab Externo 63 µm vs. 45 µm XEN® Gel Stent in Glaucoma Surgery: One-Year Follow-Up
Journal of Clinical Medicine · 19.05.2025 · 14 (10) · 3545
DOI: 10.3390/jcm14103545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.05.2025. Verfasst von Yann Bertolani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
To compare the efficacy and safety of the XEN® 63 µm and 45 µm devices with the ab externo open conjunctiva with a 30G needle approach.
Methods
A retrospective, non-randomized and single-center study was conducted. Consecutive eyes undergoing a XEN® 63 µm implant were compared with a matched cohort of cases with a XEN® 45 µm implant. Standalone and combined procedures with phacoemulsification were included.
Results
A total of 28 XEN® 45 µm and 28 XEN® 63 µm were included. Complete surgical success was achieved in 17 cases (60.7%) in the 45 µm group and in 20 cases (71.4%) in the 63 µm group, with no statistical differences. One year after the surgery, the mean IOP was 13.8 ± 3.3 mmHg for the 45 µm group and 12.4 ± 4.2 mmHg for the 63 µm group (p-value > 0.05). Likewise, the use of glaucoma medication was lowered in the 63 µm device (0.32 ± 0.87) compared to the 45 µm device (0.39 ± 0.86), with no statistical significance. Postoperative hypotony was more frequent in the 63 µm device (39.3%) than in the 45 µm group (28.6%), with no statistical differences. However, hypotony-associated complications (including choroidal detachment, hypotony keratopathy, and hypotony maculopathy) were significantly higher in the 63 µm group (p = 0.011).
Conclusions
Although the XEN® 63 µm may offer a greater IOP-lowering effect with better complete surgical success, no significant differences were detected compared to the 45 µm device. Hypotony-related complications were higher in the XEN 63 µm, although most of them resolved with conservative management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
ORCID-Profile: Yann Bertolani, Marta Castany
Zitieren
APA
Bertolani, Y., Rigo-Quera, J., Sánchez-Vela, L., Pujol-Carreras, O., Amilburu, M., Dou, A., & Castany, M. (2025). Efficacy and Safety of Open-Conjunctiva Ab Externo 63 µm vs. 45 µm XEN® Gel Stent in Glaucoma Surgery: One-Year Follow-Up. Journal of Clinical Medicine, 14(10), 3545. https://doi.org/10.3390/jcm14103545
Vancouver
Bertolani Y, Rigo-Quera J, Sánchez-Vela L, Pujol-Carreras O, Amilburu M, Dou A, et al. Efficacy and Safety of Open-Conjunctiva Ab Externo 63 µm vs. 45 µm XEN® Gel Stent in Glaucoma Surgery: One-Year Follow-Up. Journal of Clinical Medicine. 2025;14(10):3545. doi:10.3390/jcm14103545
BibTeX
@article{Bertolani2025,
author = {Bertolani, Yann and Rigo-Quera, Jaume and Sánchez-Vela, Laura and Pujol-Carreras, Olivia and Amilburu, Manuel and Dou, Antonio and Castany, Marta},
title = {Efficacy and Safety of Open-Conjunctiva Ab Externo 63 µm vs. 45 µm XEN® Gel Stent in Glaucoma Surgery: One-Year Follow-Up},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {10},
pages = {3545},
doi = {10.3390/jcm14103545}
}
EUVIMED